Biohaven Pharmaceutical (BHVN) - Periode bali modal bisnis
Heavy reliance on external contractors for drug development and production determines the baseline P/E of Biohaven Ltd. on the GURU.Markets chart, where the metric remains at -4.20. Stable demand for neurodegenerative pathology therapies sustains customer loyalty. However, a lack of operating profit and costly research force Biohaven Ltd. to constantly deplete reserves and seek external financing.
Rincian analitis perusahaan Biohaven Pharmaceutical (BHVN)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi pasar:
- data kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Biohaven Ltd.|BHVN - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Biohaven Corp|BHVN - Gunggung utang perusahaan|Utang-utang marang nilai buku Biohaven Ltd.|BHVN - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Biohaven|Rasio jangkoan perantara biohavenpharma.com
- data bathi bisnis lan rasio investasi:
BHVN - Bathi resik perusahaan|Bathi sing dikarepake Biohaven Ltd.|BHVN - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Biohaven Ltd|BHVN - Pangali PEG|Nilai perusahaan marang bathi operasional sadurunge panyusutan Biohaven Ltd.|BHVN - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Biohaven|BHVN - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan biohavenpharma.com|BHVN - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Biohaven Ltd.
Ringkesan analisis perusahaan:BHVN (biohavenpharma.com)
Searching for sustainable assets requires analyzing the price-to-earnings ratio, which allows for the determination of the premium for future growth and the risks of overpayment. In the case of Biohaven Ltd. (BHVN), the company's P/E based on net income reflects speculative expectations regarding FDA approval, as the current stage of neurological drug trials makes this metric an indicator of market confidence in a future commercial launch.
Analisis perusahaan pesaing
Rasio rega marang bathi BIIB|Pangali P/E NBIX|Periode bali modal bisnis Regencell Bioscience Ltd|Rasio rega marang bathi Axsome Therapeutics Inc AXSM|ACADIA Corp (ACAD) - Kapitalisasi marang bathi|Xenon Pharmaceuticals - Pangali P/E|Nilai perusahaan marang bathi resik VKTX (vikingtherapeutics.com)|SUPN: Pangali P/E|Catalyst Pharma (CPRX) - Pangali P/E|Koefisien rega marang bathi DNLI|Rasio rega marang bathi HRMY|Pangali P/E AMLX|TRVI - Kapitalisasi marang bathi|Rasio rega marang bathi Praxis Precision Medicines, Inc. PRAX|AVXL: Pangali rega marang bathi|CBLL: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik PRTA (Prothena Corporation)|alector.com (ALEC) - Rasio rega marang bathi|ANNX (annexonbio.com) - Rasio rega marang bathi|Koefisien rega marang bathi OMER|NGNE (Neurogene Inc) - Rasio rega pasar marang bathi resik|Pangali P/E ACIU|Voyager Corp - Pangali rega marang bathi|Neumora Therapeutics - Koefisien rega marang bathi|Periode bali modal bisnis scilexholding.com (SCLX)|Tevogen Bio - Pangali P/E|ACOG: Rasio rega marang bathi|CGTX: Pangali P/E|Inhibikase Pharma - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SAVA|Rasio rega marang bathi ASRT|Rasio rega marang bathi Coya Therapeutics, Inc. (COYA)|vistagen.com - Pangali rega marang bathi|Rasio rega marang bathi Ovid Therapeutics OVID|ABOS: Pangali rega marang bathi|CervoMed Inc. - Pangali P/E|Kapitalisasi marang bathi Alterity Therapeutics|CLNN (clene.com) - Koefisien rega marang bathi|PepGen (PEPG) - Pangali P/E|Rasio rega marang bathi Jupiter Neurosciences|RLMD: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Annovis Bio, Inc. (ANVS)|GRCE - Kapitalisasi marang bathi|Pangali P/E AIFF (Firefly Neuroscience)|ANEW Medical - Rasio rega marang bathi|NeuroSense Therapeutics, Ltd. - Pangali P/E|Periode bali modal bisnis Reviva Pharmaceuticals, Inc. RVPH|metaviatx.com (MTVA) - Rasio rega marang bathi|Kapitalisasi marang bathi neuraxis.com (NRXS)|HSDT (Helius Medical Technologies, Inc.) - Pangali P/E|PASG: Nilai perusahaan marang bathi resik|Pangali P/E NEUP|Pangali P/E Minerva (NERV)|Athira Pharma, Inc. - Koefisien rega marang bathi|addextherapeutics.com - Rasio rega marang bathi|Alzamend - Pangali P/E|Kapitalisasi marang bathi Cyclerion Therapeutics|protagenic.com (PTIX) - Rasio rega marang bathi|Pangali rega marang bathi KTTA|Koefisien rega marang bathi CRGT|ATXI: Nilai perusahaan marang bathi resik|Rasio rega marang bathi BrainStorm Cell Therapeutics (BCLI)|Rasio rega marang bathi CARA (Cara Therapeutics Inc.)|Chromocell Therapeutics Corporation - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik ELYM (Eliem Therapeutics, Inc.)|Intra-Cellular - Pangali P/E|LBPH (longboardpharma.com) - Pangali rega marang bathi|MRNS (Marinus Pharmaceuticals, Inc.) - Koefisien rega marang bathi|NKGN - Periode bali modal bisnis|NRBO (NeuroBo) - Pangali P/E|Rasio rega marang bathi SAGE|Pangali P/E SNPX|TRVN (trevena.com) - Nilai perusahaan marang bathi resik|Vigil Neuroscience, Inc. - Koefisien rega marang bathi|anewmeds.com - Rasio rega marang bathi|CERE - Rasio rega marang bathi
